In transmissible spongiform encephalopathies, the cellular prion protein (PrP C ) undergoes a conformational change from a prevailing ␣-helical structure to a ␤-sheet-rich, 
The mammalian prion diseases are a group of fatal neurodegenerative disorders that exhibit sporadic, inherited or infectious presentation (1) . These disorders are characterized by the accumulation in affected brains of a misfolded pathogenic isoform of host-encoded cellular prion protein (PrP C ), named PrP Sc , which is insoluble in nondenaturing detergents and partially resistant to proteolysis (2) . PrP
Sc and PrP C differ in their secondary and tertiary structures, but not in the amino acid sequence (3) , as an effect of increased ␤-sheet content and decreased ␣-helices in the pathological protein (4, 5) . PrP C is a glycosylphosphatidylinositol-anchored glycoprotein (6) with two potential N-linked glycosylation sites, encoded by a single gene located on human chromosome 20 (7) . In its mature form the human protein spans residues 23-231 of the polypeptide predicted from cDNA sequence and exists under diglycosylated, monoglycosylated, and unglycosylated species. PrP C is composed of an N-terminal unstructured domain, which contains four copies of an octapeptide sequence (PHGGGWGQ) between residues 60 and 91, and a C-terminal region with two short ␤-sheet structures of four residues each and three ␣-helical regions (5) . Previous studies have identified the octarepeat sequence as a Cu 2ϩ binding motif and have assessed that, in the presence of copper, each octapeptide forms an ␣-helix and acts as an ␣-helical formation promoter on the region comprising residues 84 -103 (8) . Copper binding stoichiometry is pH-dependent: four octapeptides chelate four Cu 2ϩ at pH 7.4, but bind only two Cu 2ϩ at pH 6. Under acidic conditions, Cu 2ϩ is bound by two histidine residues of different octapeptides, whereas the His-triglycine segment of a single octapeptide represents the binding site at pH 7.4 (9) . The effect of pH on PrP C conformation is not, however, limited to its influence on Cu 2ϩ . At low pH, recombinant forms of human 90 -231 (10) and murine 121-231 (11) PrP C undergo conformational changes, with an increase in ␤-sheet content and loss of ␣-helical structures.
Within a single mammalian species, PrP Sc exists under multiple conformations that are associated with distinct disease phenotypes. Upon experimental transmission, prion strains are distinguished according to differences in incubation time, regional distribution of cerebral lesions, and the pattern of proteinase K (PK) 1 -induced proteolytic cleavage of PrP Sc (12) . Biochemical evidence for the notion that PK cleaves the Nterminal region of PrP Sc at different sites in different strains has been obtained so far both in animal (13) and human (14 -16) prion diseases. In addition, based on the occupancy of the N-glycosylation sites or the ratio of the three PK-resistant PrP Sc glycoforms (diglycosylated, monoglycosylated, and unglycosylated), further biochemical types of PrP Sc have been classified (14) . Decoding the biochemical signature of individual prion strains may allow for a more precise molecular classification and may reveal environmental risk factors into human disorders with unknown etiology, such as sporadic Creutzfeldt-Jakob disease (sCJD).
In Sc upon metal-ion chelation undergo conformational changes that expose an apparently common PK cleavage site, whereas type 3 is unaffected by metal chelators (18) . Given the well known influence of pH on PrP C conformation and the lack of reports addressing the influence of pH on the conformational stability of PrP Sc , we undertook a biochemical study on sCJD PrP
Sc in an attempt to assess pH-dependent strainspecific conformations.
EXPERIMENTAL PROCEDURES
Brain Tissues-Forty-two subjects with neuropathologically confirmed diagnosis of sCJD were investigated in the present study. In all patients genomic DNA was extracted from frozen brain tissues, and the prion protein gene was sequenced as described previously (19) .
Homogenization and Fractionation-Five samples of ϳ10 mg each were obtained from the frontal cortex, occipital cortex, striatum, and cerebellum of each subject investigated. Each sample was dissolved in 9 volumes of lysis buffer (100 mM NaCl, 10 mM EDTA, 0,5% Nonidet P-40, 0.5% sodium deoxycholate, 10 mM Tris) at pH values 4, 6, 7.4, and 8, respectively, and clarified by centrifugation at 1,000 ϫ g for 10 min. The supernatant was stored at Ϫ80°C until use, whereas the pellet was discarded. Detergent-insoluble fractions were obtained by two cycles of centrifugation at 100,000 ϫ g for 90 min, as reported previously (20) .
Proteinase K and N-Glycosidase F (PNGase) F Treatments-The protease resistance was assayed by incubating sample aliquots, containing 40 g of total protein, with 100 g/ml of PK (Roche Molecular Biochemicals) for 1 h at 37°C. The digestion was blocked by the addition of phenylmethylsulfonyl fluoride to 3 mM. Samples were deglycosylated with PNGase F according to the manufacturer's instruction (Roche Molecular Biochemicals).
Immunoblots-Proteins were denatured by boiling in SDS sample buffer, separated in 13% SDS-PAGE gels, and then transferred onto polyvinylidene difluoride membranes (Immobilon-P, Millipore) for 2 h at 60 V. Membranes were blocked with 1% nonfat dry milk in TBST (TBS with 0.05% Tween 20) and probed with 3F4 antibody (Dako, Denmark), recognizing human PrP residues 109 -112, and 5B2 (21), directed to N-terminal residues 23-40. After washing the membranes were incubated with a peroxidase-conjugated anti-mouse IgG, developed using a chemiluminescent substrate (ECL, Amersham), and visualized using Biomax MR films (Eastman Kodak Co.).
RESULTS
We first used conventional Western blot methods, with lysis buffer at pH 7.4 , to analyze protease-resistant PrP Sc in all cases. Based upon the banding pattern of the three PK-resistant PrP Sc species and the apparent molecular mass of the core fragment, two types of PrP Sc were observed. In 24 subjects (MM and VV genotypes), PK-cleavage products of the three PrP Sc glycoforms migrated at ϳ30, 27, and 21 kDa (Fig. 1, lane 1) , all of them shifting to a 21-kDa zone upon deglycosylation (Fig. 1,  lane 3) , whereas in 18 subjects (MM, MV, VV genotypes) PKresistant PrP Sc species were resolved at ϳ28, 26, and 19 kDa (Fig. 1, lane 2) , with enzymatic deglycosylation yielding a band at ϳ19 kDa (Fig. 1, lane 4) . When we investigated the physicochemical properties of these two types of PrP Sc at pH values other than 7.4, three patterns could be distinguished, based on the size of PK cleavage products.
In 15 subjects (MM and VV) with the 21-kDa PrP Sc , hereafter designated as group 1, the cleavage products of the three PrP Sc bands, corresponding to the di-, mono-, and unglycosylated PK-resistant PrP Sc , as obtained at pH 4 and 6, had a molecular mass value ϳ1.5 kDa higher than digestion fragments generated at pH 7.4; conversely, when the samples were solubilized in lysis buffer at pH 8, the three PK-resistant PrP Sc glycoforms showed a faster migration, corresponding to an additional loss of ϳ1 kDa as compared with species generated at pH 7.4 (Fig. 2, A and B) . The possibility of a direct pH influence on the electrophoretic mobility of PrP Sc was ruled by exposing PK-treated and untreated samples to low and high pH before electrophoretic separation. Subjects of group 1 had a distinct clinical course with early dementia, myoclonus, and periodic sharp-wave electroencephalographic activity, overlapping the typical myoclonic sCJD variant, or cortical visual disturbances, consistent with the Heidenhain variant. These two sCJD variants represent clinical phenotypes of the classical form (17) .
In marked contrast, in 9 subjects, MM genotypes and termed group 2, with the PK-resistant fragment of 21 kDa, the migration of digestion products was insensitive to variations in pH (Fig. 2, C and D) . In these cases the three glycoforms migrated to zones of ϳ30, 27, and 21 kDa either at low or high pH. At variance with group 1, subjects of this group had an ataxicdementing sCJD variant of longer duration. Our findings suggest that the physicochemical properties of PrP Sc in group 1 and group 2, although apparently similar when examined at pH 7.4, may be further distinguished upon conformational changes induced by acidic and basic pH values.
In sCJD subjects (MM, MV, and VV genotypes, group 3) with
FIG. 1. Western immunoblot analyses of PrP
Sc from brain of representative sCJD patients after digestion by proteinase K and treatment with PNGase. Lane 1 shows a sample from the frontal cortex of an MM patient with 1-month duration classical sCJD after treatment with proteinase K; lane 3 shows the same sample after deglycosylation. Lane 2 shows a protease-digested sample from the frontal cortex of a VV patient who had ataxia at onset and late dementia, evolving over 10 months; lane 4 shows the same sample after deglycosylation. Immunoblots were prepared using 3F4 antibody; molecular masses are shown in kilodaltons.
FIG. 2. Western immunoblots with 3F4 antibody of PrP
Sc following PK treatment in the region of pH 4 -8. The frontal cortex (A, C, E) and cerebellar cortex (B, D, F) from representative sCJD subjects of group 1 (A, B), group 2 (C, D), and group 3 (E, F) are shown. On the top, pH values of lysis buffer are indicated; molecular masses are shown in kilodaltons on both sides. The size of PK-resistant PrP Sc products is affected by acidic and basic pH only in group 1 subjects, but not in groups 2 and 3. G-I show that the molecular mass of the PK-resistant deglycosylated PrP
Sc is sensitive to pH changes only in group 1; these results suggest that the conformation of both glycosylated and unglycosylated PrP Sc in group 1 is pH-dependent.
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the 19-kDa core fragment, treatment at different pH values did not affect the molecular masses of PrP Sc species generated by PK digestion (Fig. 2, E and F) .
The results obtained in each single subject were highly reproducible in at least three repetitions for a given sample and were detected in all investigated brain regions.
To confirm that changes in migration similarly affected glycosylated and unglycosylated PrP Sc species, we examined PK digestion products after removal of sugar chains. As expected, changes in pH affected only the migration of the PrP Sc core fragment of group 1 subjects (Fig. 2G) , whereas the size of the PrP Sc core fragment of group 2 ( Fig. 2H ) and 3 ( Fig. 2I ) subjects was unchanged.
To gain insight into whether naturally occurring species of the PrP Sc types detected in the three groups differed in their polypeptide backbone, detergent-insoluble PrP Sc -enriched fractions were prepared from the frontal cortex of each case and analyzed by immunoblots. In group 1 subjects, the insoluble PrP Sc had an intact N-terminal region, as suggested by comparable signal intensities with 3F4 and 5B2 antibodies (Fig. 3,  lanes 1 and 2) . Conversely, the remaining cases of groups 2 and 3 were all characterized by prevailing amounts of truncated PrP Sc fragments, as suggested by a more intense signal with 3F4 (Fig. 3, lanes 4 and 6) as compared with anti-N antibody (Fig. 3, lanes 3 and 5) , reflecting the presence of additional bands which lack the N-terminal region. These results suggest that the PrP Sc is mostly present under full-length isoforms in group 1, whereas it is mostly recovered under N-terminally truncated fragments in groups 2 and 3. Accordingly, we designated the three types of PrP Sc as type-1 full-length (FL) , type-2 truncated (T) and type-3 T . In summary, the PrP Sc bands of group 1, named type-1 FL , naturally occur as full-length species, change in conformation over the pH range 4 -8, and migrate to a 21-kDa zone after PK treatment at pH 7.4 and enzymatic deglycosylation. Conversely, type-2 T of group 2 and type-3 T detected in group 3 mostly exist as N-terminally truncated fragments, show no response to pH, and generate PK-resistant PrP Sc core fragments of 21 and 19 kDa, respectively.
Based on physicochemical properties of our three PrP Sc types under the same experimental conditions of Parchi et al. (15, 17) (see all lanes at pH 7.4 of Fig. 2, A-I (22), although different secondary cleavages are observed depending on the genotype. Accordingly, in MM and MV genotypes a secondary cleavage is observed at Gly-78, whereas in VV subjects additional N-terminal species, starting at Gly-86, are detected (22) . Interestingly, all these cleavage sites occur in the region of the third and fourth octapeptide, a region that under normal and pathological conditions may bind Cu 2ϩ . On the contrary, N-terminal species of the 19-kDa isoform start at Gly-97, in a Cu 2ϩ -free post-octarepeat domain. Two physicochemical properties of the PrP Sc associated with classical sCJD are: the acquisition of its conformation in the presence of copper (18) and a pH-dependent conformational stability (present study). Upon metal-ion chelation (in a lysis buffer at pH 7.4 and with Cu 2ϩ -chelators titrated to pH 8) (18), PK digestion products have molecular masses lower than PKresistant PrP Sc species obtained in the absence of metal chelators, thus suggesting that removal of Cu 2ϩ induces a loss of ␤-sheet conformation in the octapeptide region. Our results, showing an increase in molecular masses of PK-resistant species at low pH and a decrease at pH 8, speak in favor of an increase in ␤-sheet conformation under acidic conditions and a loss of ␤-sheets under basic conditions. Therefore, the expected loss of two Cu 2ϩ ions per PrP Sc molecule at low pH is not in keeping with the present findings, unless, as demonstrated at pH 6 for the normal octapeptide motif (9), residual Cu 2ϩ ions are shared between two histidine residues of different octapeptide chains. However, the presumed effect of pH on Cu 2ϩ binding does not fully explain results obtained at pH 4 and 8. Although it remains to be determined whether either the stoichiometry or the type of Cu 2ϩ binding are maintained after the conversion of PrP C into PrP Sc , our result may suggest a direct effect of pH on PrP Sc conformation. Why Is PrP Sc conformation pH-sensitive only in one type of the sCJD-associated proteins?
Although caution is dictated, our present results point to differences in the polypeptide backbone of the naturally occurring PrP Sc , which contains the N terminus in group 1, whereas is mostly N-terminally truncated in the other two groups. This suggests that the effect of pH on the different types of PrP Sc is strictly dependent on the presence of the N-terminal portion of the protein. Based on the present observations, it can also be suggested that, at variance with the N-terminal region, the conformation of the C-terminal portion of PrP Sc is apparently insensitive to changes in pH. This property further differentiates PrP
Sc from PrP C (10 
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the pattern of progressive fragmentation in going from pH 4 to pH 8 (see G) follows the titration curve of the imidazole ring in His. Assuming a pK ϭ 6.5, the latter would be fully protonated at pH 4 and extensively protonated (70%) at pH 6.0, but would only be 11% protonated at 7.4 and would bear only 5% positive charge at pH 8.0. The extent of His protonation, together with possible differences in the polypeptide backbone, might be responsible for the conformational transitions occurring in the type-1 FL PrP Sc reported here. Taken together, our data show evidence of three PrP Sc types in our unselected consecutive series of sCJD patients and provide a novel reproducible method to differentiate PrP Sc types in prion diseases.
